{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:50:20Z","timestamp":1767135020087,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010094","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000}}],"reference-count":80,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010094.pub2","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T15:52:50Z","timestamp":1455810770000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Radioiodine therapy versus antithyroid medications for Graves' disease"],"prefix":"10.1002","volume":"2016","author":[{"given":"Chao","family":"Ma","sequence":"first","affiliation":[{"name":"Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University; Nuclear Medicine; Kongjiang Road 1665 Shanghai Shanghai China 200092"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Xie","sequence":"additional","affiliation":[{"name":"Putuo Liqun Hospital; Stomatology; Shanghai Shanghai China 200092"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University; Nuclear Medicine; Kongjiang Road 1665 Shanghai Shanghai China 200092"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University; Nuclear Medicine; Kongjiang Road 1665 Shanghai Shanghai China 200092"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Affiliated XinHua Hospital of Medical School Shanghai Jiaotong University; Nuclear Medicine; Kongjiang Road 1665 Shanghai Shanghai China 200092"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,2,18]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD010094.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/thy.2005.15.1279","article-title":"Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery","volume":"15","author":"Abraham-Nordling","year":"2005","journal-title":"Thyroid"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.1.02336","article-title":"Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease","volume":"156","author":"Abraham-Nordling","year":"2007","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/thy.1998.8.653","article-title":"Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study","volume":"8","author":"Ljunggren","year":"1998","journal-title":"Thyroid"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0006|cit5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism, the thyroid study group","volume":"326","author":"Tallstedt","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0005|cit6","first-page":"2986","article-title":"Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study, thyroid study group","volume":"81","author":"T\u00f6rring","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD010094.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-10-0475","article-title":"Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine","volume":"163","author":"Abraham-Nordling","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"Tr\u00e4isk","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/eje.1.01904","article-title":"Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine","volume":"152","author":"Azizi","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2796.1996.441788000.x","article-title":"Clinical\u00a0outcome\u00a0of\u00a0radioiodine\u00a0treatment\u00a0of\u00a0hyperthyroidism: a\u00a0follow-up study","volume":"239","author":"Berg","year":"1996","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2796.1991.tb00371.x","article-title":"The\u00a0incidence\u00a0of\u00a0recurrence\u00a0and\u00a0hypothyroidism\u00a0following\u00a0treatment\u00a0with\u00a0antithyroid drugs,\u00a0surgery\u00a0or radioiodine\u00a0in all\u00a0patients\u00a0with\u00a0thyrotoxicosis\u00a0in Malm\u00f6 during the\u00a0period\u00a01970-1974","volume":"229","author":"Berglund","year":"1991","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0013|cit13","first-page":"334","article-title":"Therapeutic effect of 131I and prednisone on Graves' ophthalmopathy","volume":"28","author":"Chen","year":"2005","journal-title":"Journal of Luzhou Medical College"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0014|cit14","first-page":"507","article-title":"Comparison of efficacy of 131 I and antithyroid drugs in the treatment of Graves' disease in children","volume":"43","author":"Chen","year":"2005","journal-title":"Chinese Journal Pediatrics"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MNM.0b013e3283134d4d","article-title":"Comparison of the long-term efficacy of low dose 131I versus antithyroid drugs in the treatment of hyperthyroidism","volume":"30","author":"Chen","year":"2009","journal-title":"Nuclear Medicine Communications"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10792-010-9368-x","article-title":"Association between radioiodine therapy for Graves' hyperthyroidism and thyroid-associated ophthalmopathy","volume":"30","author":"El-Kaissi","year":"2010","journal-title":"International Ophthalmology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0017|cit17","first-page":"87","article-title":"Cost-utility\u00a0analysis\u00a0of\u00a0antithyroid drug\u00a0therapy\u00a0versus 131I\u00a0therapy\u00a0for\u00a0Graves'\u00a0disease","volume":"42","author":"Hayashi","year":"2005","journal-title":"Kakuigaku. The Japanese Journal of Nuclear Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0018|cit18","first-page":"273","article-title":"Long term effects of the treatment of the Graves' disease by 4 different therapeutics (author's transl)","volume":"38","author":"Mornex","year":"1977","journal-title":"Annales D'endocrinologie"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2006.16.593","article-title":"The cost effectiveness of treatment modalities for thyrotoxicosis in a U.K. center","volume":"16","author":"Patel\u00a0NN","year":"2006","journal-title":"Thyroid"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0020|cit20","first-page":"138","article-title":"Long-term comparative cancer mortality after use of radio-iodine in the treatment of hyperthyroidism, a fully reported multicenter study","volume":"33","author":"Singer","year":"2001","journal-title":"Journal of Insurance Medicine (New York, NY)"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0021|cit21","first-page":"2801","article-title":"Clinical observation of therapeutic effect of 131I and prednisone on Graves' ophthalmopathy","volume":"5","author":"Hui","year":"2005","journal-title":"Chinese Journal of Misdiagnostics"},{"issue":"1","key":"10.1002\/14651858.CD010094.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003420.pub3","article-title":"Antithyroid drug regimen for treating Graves' hyperthyroidism","author":"Abraham","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010094.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2265.2008.03279.x","article-title":"Radioiodine therapy for Graves' disease and the effect on ophthalmopathy: a systematic review","volume":"69","author":"Acharya","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0002-9343(91)90577-K","article-title":"Bone mineral density in postmenopausal women treated with L-thyroxine","volume":"90","author":"Adlin","year":"1991","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"\u00a0675","DOI":"10.1210\/jcem-70-3-675","article-title":"Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration","volume":"70","author":"Allannic","year":"1990","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0026|cit26","first-page":"1006","article-title":"Thyroid cancer prevalence after radioiodine treatment of hyperthyroidism","volume":"41","author":"Angusti","year":"2000","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0027|cit27","first-page":"477","article-title":"Long-term continuous methimazole or radioiodine treatment for hyperthyroidism","volume":"15","author":"Azizi","year":"2012","journal-title":"Archives of Iranian Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010094.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American thyroid association and American association of clinical endocrinologists","volume":"21","author":"Bahn Chair","year":"2011","journal-title":"Thyroid"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2011.09.004","article-title":"Prevention of Graves' ophthalmopathy","volume":"26","author":"Bartalena","year":"2012","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1056\/NEJM198408163110710","article-title":"Choice of therapy for Graves' hyperthyroidism","volume":"311","author":"Becker","year":"1984","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2046-4053-2-36","article-title":"Are systematic reviews up-to-date at the time of publication?","volume":"2","author":"Beller","year":"2013","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2796.1996.415757000.x","article-title":"Increased incidence of thyrotoxicosis in Malmo during the years 1988-1990 as compared to the years 1970-1974","volume":"239","author":"Berglund","year":"1996","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0033|cit33","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-28026-2","volume-title":"Clinical Nuclear Medicine","author":"Biersack","year":"2007"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0034|cit34","first-page":"334","article-title":"Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine","volume":"77","author":"Biondi","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1200\/JCO.2014.56.7503","article-title":"Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled t rial","volume":"32","author":"Boutron","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0036|cit36","first-page":"424","article-title":"Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism","volume":"340","author":"Bunevicius","year":"1999","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1461145700001826","article-title":"Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism","volume":"1","author":"Bunevicius","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0039|cit39","first-page":"173","article-title":"Mechanisms of chemical injury of thyroid gland","volume":"387","author":"Capen","year":"1994","journal-title":"Progress in Clinical and Biological Research"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0040|cit40","first-page":"442","article-title":"Iodine-131 therapy of hyperthyroidism in pediatric patients","volume":"36","author":"Clark","year":"1995","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198411223112106","article-title":"Antithyroid drugs","volume":"311","author":"Cooper","year":"1984","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0042|cit42","first-page":"7","article-title":"Cost-effectiveness analysis: radioiodine or antithyroid medication in primary treatment of immune hyperthyroidism","volume":"38","author":"Dietlein","year":"1999","journal-title":"Nuclear-Medizin"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM196411122712004","article-title":"Rising incidence of hypothyroidism after radioactive iodine therapy in hyperthyroidism","volume":"271","author":"Dunn","year":"1964","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1530\/eje.0.1300350","article-title":"Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis","volume":"130","author":"Faber","year":"1994","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0045|cit45","first-page":"251","article-title":"The management of Graves' disease in New Zealand: results of a national survey","volume":"104","author":"Ford","year":"1991","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199803123381103","article-title":"Mortality\u00a0after\u00a0the\u00a0treatment\u00a0of\u00a0hyperthyroidism\u00a0with\u00a0radioactive\u00a0iodine","volume":"338","author":"Franklyn","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010094.pub2-BIB0047|cit47","first-page":"575","article-title":"Diagnosis and management of Graves' disease","volume":"168","author":"Ginsberg","year":"2003","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1289\/ehp.106-1533202","article-title":"Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis","volume":"106","author":"Hard","year":"1998","journal-title":"Environmental Health Perspectives"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0051|cit51","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0053|cit53","first-page":"108","article-title":"Changing annual incidence of hypothyroidism after 131I therapy for hyperthyroidism, 1951-1975","volume":"23","author":"Holm","year":"1982","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"10.1002\/14651858.CD010094.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1503\/cmaj.120744","article-title":"Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors","volume":"185","author":"Hr\u00f3bjartsson","year":"2013","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-121-10-199411150-00005","article-title":"Large compressive goiters treated with radioiodine","volume":"121","author":"Huysmanns","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(82)92348-0","article-title":"We need thyroid follow-up registers? a cost effective study","volume":"1","author":"Jones","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12916-015-0520-3","article-title":"Comparison of registered and published outcomes in randomized controlled trials: a systematic review","volume":"13","author":"Jones","year":"2015","journal-title":"BMC Medicine"},{"issue":"6441","key":"10.1002\/14651858.CD010094.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/bmj.289.6441.361","article-title":"Ablative radioiodine therapy for hyperthyroidism: long term follow up study","volume":"28","author":"Kendall-Taylor","year":"1984","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/bjo.88.1.72","article-title":"The relation of Graves' ophthalmopathy to circulating thyroid hormone status","volume":"88","author":"Kim","year":"2004","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD010094.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"1999","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010094.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006294.pub2","article-title":"Radioiodine treatment for pediatric Graves' disease","author":"Ma","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD010094.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/MNM.0b013e32832c79e0","article-title":"Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism","volume":"30","author":"Ma","year":"2009","journal-title":"Nuclear Medicine Communications"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.2009.1242","article-title":"Comparison of registered and published primary outcomes in randomized controlled trials","volume":"302","author":"Mathieu","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2046-4053-3-82","article-title":"A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation","volume":"3","author":"Meader","year":"2014","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s002590050234","article-title":"The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodination in 1990","volume":"25","author":"Mostbeck","year":"1998","journal-title":"European Journal of Nuclear Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0068|cit68","first-page":"1516","article-title":"The European multicenter study group on antithyroid drug treatment. a prospective randomized trial of antithyroid drug dose in Graves' disease","volume":"6","author":"Reinwein","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.1997.03540390068038","article-title":"Thyroid storm","volume":"277","author":"Rennie","year":"1997","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD010094.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.280.4.347","article-title":"Cancer\u00a0mortality\u00a0following\u00a0treatment\u00a0for\u00a0adult\u00a0hyperthyroidism.\u00a0Cooperative Thyrotoxicosis Therapy Follow-up Study Group","volume":"280","author":"Ron","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM198408163110702","article-title":"Long-term follow up study of compensated low dose 131I therapy","volume":"311","author":"Sridama","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.eye.6702603","article-title":"Cigarette smoking and thyroid eye disease: a systematic review","volume":"21","author":"Thornton","year":"2007","journal-title":"Eye (London, England)"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey","volume":"43","author":"Vanderpump","year":"1995","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti","year":"1997","journal-title":"Thyroid"},{"key":"10.1002\/14651858.CD010094.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States","volume":"1","author":"Wartofsky","year":"1991","journal-title":"Thyroid"},{"issue":"5","key":"10.1002\/14651858.CD010094.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2265.1988.tb03683.x","article-title":"Outcome following standardized 185MB dose 131I therapy for Graves' disease","volume":"28","author":"Watson","year":"1988","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD010094.pub2-BIB0079|cit79","first-page":"41","article-title":"Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE","volume":"94","author":"Wong","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"7644","key":"10.1002\/14651858.CD010094.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010094.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T07:02:09Z","timestamp":1695452529000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010094.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Metabolic and Endocrine Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,18]]},"references-count":80,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010094.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,18]]}}}